Electroceuticals spark interest (original) (raw)

Industry and academia invest in treating diseases by delivering electrical charges to nerves.

Access through your institution

Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Learn more

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Authors

  1. Sara Reardon
    View author publications
    Search author on:PubMed Google Scholar

FDA Approves First Retinal Implant 2013-Feb-15

Seizure detector treats epilepsy in rats 2012-Aug-09

Indirect brain treatment may relieve Parkinson's symptoms 2009-Mar-19

SPARC

GSK bioelectronics programme

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reardon, S. Electroceuticals spark interest.Nature 511, 18 (2014). https://doi.org/10.1038/511018a

Download citation

This article is cited by